DNA plasmid HIV vaccine design, number of doses, participant gender, and body mass index affect T-cell responses across HIV vaccine clinical trials. - Morgan, C.; Jin, X.; Yu, X.; De Rosa, S.; Kublin, J.; Metch, B.; Keefer, M.; Niaid, H. (Retrovirology, 2012)